Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 237 | 669 | 2,536 | 3,061 | 5,734 |
| Gross Profit | 237 | 669 | 2,536 | 3,061 | 5,734 |
| Operating Expenses | 25,947 | 35,088 | 38,996 | 42,363 | 50,777 |
| Operating Income | -25,710 | -34,419 | -36,460 | -39,302 | -45,043 |
| Interest Expense | 1,154 | 1,396 | 1,721 | 939 | 1,719 |
| Other Income | 249 | 357 | 158 | 3,565 | 3,760 |
| Pre-tax Income | -26,615 | -35,458 | -38,023 | -36,676 | -43,002 |
| Net Income Continuous | -26,615 | -35,458 | -38,023 | -36,676 | -43,002 |
| Net Income | $-26,615 | $-35,458 | $-38,023 | $-36,676 | $-43,002 |
| EPS Basic Total Ops | -26.25 | -50.75 | -84.70 | -105.71 | -150.51 |
| EPS Basic Continuous Ops | -26.18 | -50.62 | -84.83 | -105.60 | -150.36 |
| EPS Diluted Total Ops | -26.25 | -50.75 | -84.70 | -105.71 | -159.96 |
| EPS Diluted Continuous Ops | -26.18 | -50.62 | -84.83 | -105.60 | -146.81 |
| EPS Diluted Before Non-Recurring Items | -26.25 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-25,509 | $-34,141 | $-36,090 | $-39,140 | $-44,647 |